title: Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure.
abstract: Heart failure (HF) and obesity are major public health problems. Studies have shown that obesity may increase the risk of developing new HF but after patients have developed HF, obesity may be associated with improved outcomes. This paradoxical association of obesity with HF remains poorly understood. It is believed that the obesity paradox may in part be due to the inherent limitations of body mass index (BMI) as a measure of obesity. BMI may not appropriately measure important components of body mass like body fat, fat distribution, lean body mass, and body fluid content and may not be ideal for examining the relationship of body composition with health outcomes. Differentiating between body fat and lean body mass may explain some of the paradoxical association between higher BMI and better prognosis in patients with HF. Paradoxical outcomes in HF may also be due to phenotypes of obesity. Future studies need to develop and test metrics that may better measure body composition and may serve as a better tool for the estimation of the true association of obesity and outcomes in HF and determine whether the association may vary by obesity phenotypes. KEY MESSAGES Obesity predisposes to heart failure in all age groups. But obesity in heart failure is an area of controversy, because of obesity paradox, the apparent protective effect of overweight and mild obesity on mortality after development of heart failure. Traditional markers of obesity do not measure different components of body weight like muscle mass, fat, water, and skeletal weight. Body Mass Index in heart failure subjects does not measure accurately body fat or fluid retention. So new markers of obesity like visceral adiposity index, body composition analysis, sarcopenic status assessment may be helpful in the assessment of heart failure outcomes. Different phenotypes of obesity may be responsible for the different morbidity, mortality as well as therapeutic outcomes in heart failure.
authors.affiliation: a Department of Medicine , University of Alberta , Edmonton , Canada.
authors.forename: Kannayiram
authors.initials: K
authors.lastname: Alagiakrishnan
authors.affiliation: b Department of Hypertension , Medical University of Lodz , Zeronskiego , Poland.
authors.forename: Maciej
authors.initials: M
authors.lastname: Banach
authors.affiliation: c Veterans Affairs Medical Center , George Washington University , Washington , DC , USA.
authors.forename: Ali
authors.initials: A
authors.lastname: Ahmed
authors.affiliation: d Division of Cardiology, Geriatrics, Pulmonary and Critical Care, Department of Medicine , New York Medical College , Valhalla , NY , USA.
authors.forename: Wilbert S
authors.initials: WS
authors.lastname: Aronow
mesh_terms: D000273:Adipose Tissue / Q000502:physiology; D001823:Body Composition; D015992:Body Mass Index; D005260:Female; D006333:Heart Failure / Q000401:mortality / Q000503:physiopathology*; D006801:Humans; D008297:Male; D009765:Obesity / Q000503:physiopathology*; D011379:Prognosis; D018570:Risk Assessment
keywords: Heart failure; mortality; obesity; obesity paradox; obesity phenotypes